翻訳と辞書 |
Agios Pharmaceuticals : ウィキペディア英語版 | Agios Pharmaceuticals
Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway.〔〔 Among the proteins under investigation by the company are IDH1 and IDH2.〔 The company was founded in 2008 (or 2007)〔 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts.〔〔 The company tendered an initial public offering in July 2013.〔 In 2012, Agios was named among the defendants in a lawsuit against one of its founders, Craig Thompson, alleging that Thompson used research illegally taken from the Abramson Family Cancer Research Institute in research at Agios.〔 ==Corporate governance== , Agios' CEO was David Schenkein.〔 Agios was established as a private company and converted to a public company with its initial public offering in July 2013 and subsequent listing on NASDAQ.〔〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Agios Pharmaceuticals」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|